Unknown NA INTERVENTIONAL 2-arm NCT03892070

Beta-Hydroxy-Beta-Methylbutyrate Supplementation and Physical Activity in Liver Cirrhosis: a Controlled Trial (HMB)

Sponsor: University of Roma La Sapienza

Interventions BETA-HYDROXY-BETA-METHYLBUTYRATE (HMB) Mannitol

Updated 5 times since 2019 Last updated: Mar 25, 2019 Started: Mar 1, 2019 Primary completion: Dec 10, 2019 Completion: Sep 10, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03892070, this NA trial focuses on Cirrhosis, Liver and Sarcopenia and remains ongoing. Sponsored by University of Roma La Sapienza, it has been updated 5 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Oct 2021 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jan 2021 — Oct 2021 [monthly]

Recruiting NA
Apr 2019 — Jan 2021 [monthly]

Recruiting NA

First recorded

Mar 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Roma La Sapienza

Data source: University of Roma La Sapienza

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rome, Italy